February 27, 2018 / 10:01 PM / 7 months ago

BRIEF-Five Prime Reports Q4 Loss Per Share $1.04

Feb 27 (Reuters) - Five Prime Therapeutics Inc:

* FIVE PRIME ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

* Q4 LOSS PER SHARE $1.04

* FIVE PRIME THERAPEUTICS - CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES TOTALED $292.7 MILLION ON DEC 31, 2017 VERSUS $421.7 MILLION ON DECEMBER 31, 2016 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below